Expanded spectrum of recombinant human growth hormone therapy

Current Opinion in Pediatrics

Volumn 14, Issue 4, 2002, Pages 437-442

  Henwood, Maria J ^a   Grimberg, Adda ^a   Moshang Jr , Thomas ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

CHILD; CHILD GROWTH; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HUMAN; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TURNER SYNDROME;

ADULT; BODY HEIGHT; CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; RECOMBINANT PROTEINS;

EID: 0036064876     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200208000-00015     Document Type: Review

References (45)

1. Between-assay differences in serum growth hormone (GH) measurements: Importance in the diagnosis of GH deficiency in childhood
2. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society
3. Determination of insulin-like growth factor 1 in children: Normal values and clinical use
4. Growth hormone safety update from the National Cooperative Growth Study
5. High-dose growth hormone treatment of short children born small for gestational age
6. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
7. Short-term tools to measure responsiveness to growth hormone replacement
8. Final height following growth hormone treatment of idiopathic growth hormone deficiency in KIGS
9. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naïve pediatric patients with GH deficiency
10. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: Implications for efficacy and safety
11. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women
12. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia
13. Long-term effect of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency
14. Growth over 10 years following a 1-year trial of growth hormone therapy
15. Effect of growth hormone treatment on the adult height of children with chronic renal failure
16. Does recombinant growth hormone improve adult height in children with chronic renal failure?
17. Growth hormone treatment in children with chronic renal failure: A meta-analysis of randomized controlled trials
18. Intraperitoneal administration of recombinant human growth hormone in children with end-stage renal disease
19. IGF-I resistance and Turner's Syndrome
20. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: Results of a randomized dose-response trial
21. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome
22. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency
23. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome
24. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance
25. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study
26. Recombinant human growth hormone in short children born small for gestational age
27. Growth hormone treatment of short children born small for gestational age
28. Final height of short subjects of low birth weight with and without growth hormone treatment
29. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pre-treatment GH secretion and associated with a reversible decrease in insulin sensitivity
30. Effect of growth hormone therapy on height in children with idiopathic short stature
31. Final height gain by GH therapy in children with idiopathic short stature is dose dependent
32. Growth hormone therapy for short stature: Panacea or Pandora's box?
33. Growth response, pubertal growth and FH in Greek children with growth hormone (GH) deficiency on long-term GH therapy and factors affecting outcome
34. The effect of pubertal delay by GnRH agonist in GH-deficient children on final height
35. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on final height of girls with isolated GH deficiency: Results of a controlled study
36. Growth hormone treatment during suppression of early puberty in adopted girls
37. Combined therapy with GnRH analog plus growth hormone in central precocious puberty
38. Randomised trial of LHRH analogue treatment on FH in girls with onset of puberty aged 7.5-8.5 years
39. Growth hormone therapy and growth in children with Noonan's syndrome: Results of 3 years' follow-up
40. Growth hormone treatment in children with Noonan's syndrome: Four year results of a partly controlled trial
41. Short stature in Noonan syndrome: Response to growth hormone therapy
42. GH therapy in juvenile chronic arthritis: Results of a two-year controlled study on growth and bone
43. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton)
44. Growth hormone improves clinical status in prepubertal children with cystic fibrosis: Results of a randomized controlled trial
45. Effective growth hormone therapy in a growth hormone deficient patient with Duchenne muscular dystrophy without evidence of acceleration of the dystrophic process